{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:09:04Z","timestamp":1774314544802,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,16]]},"DOI":"10.7759\/cureus.96957","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T11:33:06Z","timestamp":1763292786000},"source":"Crossref","is-referenced-by-count":1,"title":["From Seizures to Behavioral Symptoms: A Case Series of Psychiatric Adverse Effects of Levetiracetam in Epilepsy Patients"],"prefix":"10.7759","author":[{"given":"Ravindra K","family":"Ganjikunta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya Deepti","family":"Udaragudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Chalivendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umamaheswara Rao","family":"Kaveti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"K Mallaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition","author":"Brunton LL","year":"2023","unstructured":"Brunton LL, Knollmann BC. Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition. Brunton LL, Knollmann BC (ed): McGraw Hill, Columbus, OH; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest KM","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S, et al.. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017, 88:296-303. 10.1212\/WNL.0000000000003509","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.01.038","article-title":"Epilepsy: a clinical overview","volume":"134","author":"Milligan TA","year":"2021","unstructured":"Milligan TA. Epilepsy: a clinical overview. Am J Med. 2021, 134:840-7. 10.1016\/j.amjmed.2021.01.038","journal-title":"Am J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi E","year":"2020","unstructured":"Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020, 54:185-91. 10.1159\/000503831","journal-title":"Neuroepidemiology"},{"key":"ref5","article-title":"Behavioral and emotional effects of levetiracetam in children with intractable epilepsy","volume":"43","author":"Gustafson MC","year":"2002","unstructured":"Gustafson MC, Ritter FJ, Frost MD, Karney V, Hoskin C. Behavioral and emotional effects of levetiracetam in children with intractable epilepsy. Epilepsia. 2002, 43:58.","journal-title":"Epilepsia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2014.06.004","article-title":"Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review","volume":"23","author":"Halma E","year":"2014","unstructured":"Halma E, de Louw AJ, Klinkenberg S, Aldenkamp AP, IJff DM, Majoie M. Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review. Seizure. 2014, 23:685-91. 10.1016\/j.seizure.2014.06.004","journal-title":"Seizure"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2019.01.004","article-title":"Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy","volume":"150","author":"Thelengana A","year":"2019","unstructured":"Thelengana A, Shukla G, Srivastava A, et al.. Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy. Epilepsy Res. 2019, 150:58-65. 10.1016\/j.eplepsyres.2019.01.004","journal-title":"Epilepsy Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen B","year":"2017","unstructured":"Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Buchsbaum R, Detyniecki K. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017, 76:24-31. 10.1016\/j.yebeh.2017.08.039","journal-title":"Epilepsy Behav"},{"key":"ref9","unstructured":"WHO-UMC system for standardized case causality assessment. (2025). Accessed. November 16, 2025: https:\/\/www.who-umc.org\/media\/2768\/standardised-case-causality-assessment.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.05.012","article-title":"Positive and negative psychotropic effects of levetiracetam","volume":"13","author":"Helmstaedter C","year":"2008","unstructured":"Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE. Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav. 2008, 13:535-41. 10.1016\/j.yebeh.2008.05.012","journal-title":"Epilepsy Behav"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000078031.32904.0d","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula M","year":"2003","unstructured":"Mula M, Trimble MR, Yuen A, Liu RS, Sander JW. Psychiatric adverse events during levetiracetam therapy. Neurology. 2003, 61:704-6. 10.1212\/01.wnl.0000078031.32904.0d","journal-title":"Neurology"},{"key":"ref12","article-title":"Levetiracetam: a review of its use in epilepsy","volume":"71","author":"Lyseng-Williamson KA","year":"2011","unstructured":"Lyseng-Williamson KA. Levetiracetam: a review of its use in epilepsy. Drugs. 2011, 71:489-514.","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107939","article-title":"Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review","volume":"118","author":"Steinhoff BJ","year":"2021","unstructured":"Steinhoff BJ, Klein P, Klitgaard H, et al.. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review. Epilepsy Behav. 2021, 118:107939. 10.1016\/j.yebeh.2021.107939","journal-title":"Epilepsy Behav"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2003.07.008","article-title":"Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases","volume":"4","author":"Dinkelacker V","year":"2003","unstructured":"Dinkelacker V, Dietl T, Widman G, Lengler U, Elger CE. Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases. Epilepsy Behav. 2003, 4:537-47. 10.1016\/j.yebeh.2003.07.008","journal-title":"Epilepsy Behav"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730070-00001","article-title":"Negative effects of antiepileptic drugs on mood in patients with epilepsy","volume":"30","author":"Mula M","year":"2007","unstructured":"Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007, 30:555-67. 10.2165\/00002018-200730070-00001","journal-title":"Drug Saf"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.19202","article-title":"Behavioral effects of levetiracetam mitigated by pyridoxine","volume":"19","author":"Davis GP","year":"2009","unstructured":"Davis GP, McCarthy JT, Magill DB, Coffey B. Behavioral effects of levetiracetam mitigated by pyridoxine. J Child Adolesc Psychopharmacol. 2009, 19:209-11. 10.1089\/cap.2009.19202","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8883802","article-title":"Levetiracetam induced behavioral abnormalities in a patient with seizure disorder: a diagnostic challenge","volume":"2020","author":"Ogunsakin O","year":"2020","unstructured":"Ogunsakin O, Tumenta T, Louis-Jean S, Mahbub A, Rabel P, Olupona T, Alam S. Levetiracetam induced behavioral abnormalities in a patient with seizure disorder: a diagnostic challenge. Case Rep Psychiatry. 2020, 2020:8883802. 10.1155\/2020\/8883802","journal-title":"Case Rep Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5586","article-title":"Levetiracetam-induced aggression and acute behavioral changes: a case report and literature review","volume":"10","author":"Zhang JF","year":"2022","unstructured":"Zhang JF, Piryani R, Swayampakula AK, Farooq O. Levetiracetam-induced aggression and acute behavioral changes: a case report and literature review. Clin Case Rep. 2022, 10:e05586. 10.1002\/ccr3.5586","journal-title":"Clin Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, antiepileptic drugs, and aggression: an evidence-based review","volume":"68","author":"Brodie MJ","year":"2016","unstructured":"Brodie MJ, Besag F, Ettinger AB, et al.. Epilepsy, antiepileptic drugs, and aggression: an evidence-based review. Pharmacol Rev. 2016, 68:563-602. 10.1124\/pr.115.012021","journal-title":"Pharmacol Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2064027","article-title":"Mechanisms underlying aggressive behavior induced by antiepileptic drugs: focus on topiramate, levetiracetam, and perampanel","volume":"2018","author":"Hansen CC","year":"2018","unstructured":"Hansen CC, Ljung H, Brodtkorb E, Reimers A. Mechanisms underlying aggressive behavior induced by antiepileptic drugs: focus on topiramate, levetiracetam, and perampanel. Behav Neurol. 2018, 2018:2064027. 10.1155\/2018\/2064027","journal-title":"Behav Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/436451-from-seizures-to-behavioral-symptoms-a-case-series-of-psychiatric-adverse-effects-of-levetiracetam-in-epilepsy-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T11:33:07Z","timestamp":1763292787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/436451-from-seizures-to-behavioral-symptoms-a-case-series-of-psychiatric-adverse-effects-of-levetiracetam-in-epilepsy-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.96957","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,16]]}}}